Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Ad Division Director Abrams Brings Sales Rep Experience To Head Post

Executive Summary

The newly announced permanent director of FDA's Division of Drug Marketing, Advertising & Communications Tom Abrams brings seven years of industry sales & marketing experience to the post.

You may also be interested in...



FDA regulatory counsel

Center for Drug Evaluation & Research is recruiting a second regulatory counsel for the Division of Drug Marketing, Advertising & Communications. FDA's ad division said it requires additional legal counsel in order to support enforcement actions responding to the entire marketplace, including exhibit hall and Internet promotion. The Bush Administration's hiring freeze will temporarily prevent FDA from completing the hire. FDA is not currently looking to fill the ad division's deputy director position, which has remained vacant since Tom Abrams became permanent director of the division in February 2000 (1"The Pink Sheet" Feb. 21, 2000, p. 29)

FDA regulatory counsel

Center for Drug Evaluation & Research is recruiting a second regulatory counsel for the Division of Drug Marketing, Advertising & Communications. FDA's ad division said it requires additional legal counsel in order to support enforcement actions responding to the entire marketplace, including exhibit hall and Internet promotion. The Bush Administration's hiring freeze will temporarily prevent FDA from completing the hire. FDA is not currently looking to fill the ad division's deputy director position, which has remained vacant since Tom Abrams became permanent director of the division in February 2000 (1"The Pink Sheet" Feb. 21, 2000, p. 29)

WLF Appeals Court Decision Leaves Free Speech Question Open

FDA's ability to introduce sponsor dissemination of off-label reprints as evidence in enforcement action litigation may be the next item open for constitutional questioning, following the Feb. 11 dismissal of Washington Legal Foundation v. Henney by the Washington D.C. appeals court.

Related Content

UsernamePublicRestriction

Register

OM004634

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel